Pharmacy Technician Course
|
|
|
- Amie Stokes
- 5 years ago
- Views:
Transcription
1 Pharmacy Technician Course VERSION HISTORY SECTION 1: History and Scope of the Pharmacy Technician Scope of the Pharmacy Technician Section 1 Quiz Check Your Knowledge Section 1 Quiz Answers SECTION 2: Manufacturing Pharmaceuticals Section 2 Quiz Check Your Knowledge Section 2 Quiz Answers SECTION 3: Rules and Regulations (PTCB 2.0) Omnibus Budget Reconciliation Act of 1990 (OBRA 90)(PTCB 2.9) Poison Prevention Packaging Act of 1970 (PPPA) Health Insurance Portability and Accountability Act (HIPAA) (PTCB 2.8) Combat Methamphetamine Epidemic Act of 2005 (CMEA) Manufacturer Drug Package Labeling Repackaging Medications (PTCB 2.12) Therapeutic Equivalence (PTCB 1.2) Section 3 Quiz Check Your Knowledge Section 3 Quiz Answers SECTION 4: Controlled Substances (PTCB 2.4) Schedule for Controlled Substances Forms Required for Storing, Maintaining and Distributing Controlled Substances(PTCB 2.3, 2.4) Storage and Record Keeping for Controlled Substances Prescribing and Filling Rules and Regulations for Controlled Substances Prescribing Rules for Schedule C-III to C-V Medications for Treatment of Addiction (buprenorphine) Validating Prescribers
2 Section 4 Quiz Check Your Knowledge Section 4 Quiz Answers SECTION 5: Pharmacy Safety Storage and Handling of Hazardous Substances (PTCB 2.1, 2.2) Hazardous Drugs Drugs That Can Have Very High Risk Side Effects Restricted Drug Programs(PTCB 2.7) Frequently Used REMS System for Thalidomide Education and Prescribing Safety Medication Safety (PTCB 4.3) Look Alike Sound Alike Medications (PTCB 4.4) Common Drug Interactions (PTCB 1.3) Drug Drug Interactions Drug Food Interactions Drug Disease Interaction Section 5 Quiz Check Your Knowledge Section 5 Quiz Answers SECTION 6: Drug Classifications (PTCB Pharmacology ) Drugs For the Treatment of Hypertension Angiotensin Converting Enzyme (ACE) Inhibitors Angiotensin Receptor Blockers (ARB) Thiazide Diuretics and Loop Diuretics Potassium Sparing Diuretics Alpha1 Blockers (Antagonist Blocks the Receptor) Alpha2 Receptor Agonist (Activates the Receptor) Beta Blockers (Antagonist Blocks the Receptor) Calcium Channel Blockers Drugs Used to Treat Cholesterol HMG-CoA Reductase Inhibitors (Statins) Drugs Used to Treat Diabetes
3 Insulin Biguanides Dipeptidyl Peptidase-4 Inhibitors Sulfonylureas GLP-1 Agonist (Activates the Receptor) Drugs Used to Treat Heart Conditions Vasodilators (Make Blood Vessels Larger) Antiarrhythmics (For Cardiac Arrhythmias) Drugs Used to Prevent or Treat Blood Clots Anticoagulants Antiplatelet Medications Medications Used to Treat Psychiatric Disorders Selective Serotonin Reuptake Inhibitors (SSRI) Serotonin-Norepinephrine Reuptake Inhibitors (SNRI) Drug Forms (PTCB 1.4) Release of Medications into the Body Liquid Dosage Forms Medication Labelling Section 6 Quiz Check Your Knowledge Section 6 Quiz Answers SECTION 7: Sterile and Non-Sterile Compounding (PTCB ) Equipment Used in Compounding (PTCB 3.5) Electronic Pharmacy Balance Class A Prescription Balance Alligation Sterile Compounding (PTCB 3.6) United States Pharmacopeia (USP) Chapter 797 Beyond Use Date (BUD) (PTCB 3.4) The International Organization for Standardization (ISO)
4 Common Abbreviations Used in a Clean Room Non-Sterile Compounding (PTCB 3.7) Common Abbreviations Used in Compounding Section 7 Quiz Test Your Knowledge Section 7 Quiz Answers SECTION 8: Pharmacy Quality Assurance (PTCB ) Recalls Medication Order Entry and Fill Process (PTCB ) Medication Dosing Administration Routes Units of Measure Section 8 Quiz Check Your Knowledge Section 8 Quiz Answers SECTION 9 Mathematics in Pharmacy (PTCB 3.6, 6.3) Fractions The Basics Common Denominator Reducing Fractions Adding Fractions Subtracting Fractions Multiply Fractions Divide Fractions Converting Fractions To Decimals Percentages To Fractions Fractions Converted To Percent Practical Application Avoirdupois System (United States) The Metric System Standard System of Measure for Medicine (and Pharmacy) Roman Numerals Calculating Averages
5 Section 9 Quiz Check Your Knowledge Section 9 Quiz Answers SECTION 10: Inventory Management (PTCB ) National Drug Code Number (NDC) Maintaining Inventory Maintaining a Safe Inventory Rotating Stock Storing Medications Safely Section 10 Quiz Test Your Knowledge Section 10 Quiz Answers SECTION 11: Pharmacy Billing and Reimbursement (PTCB 8.0) Different Types of Insurance Companies Section 11 Quiz Check Your Knowledge Section 11 Quiz Answers SECTION 12: Information Systems (PTCB 9.0) Bibliography Appendix A Alphabetically by Brand Name Alphabetically by Generic Name Appendix B Categories of Medications and their Purpose Appendix C Common Medications by Categories Alphabetically by Brand Name Alphabetically by Drug Category Alphabetically by Generic Name
About the PCTB Examination Assisting the Pharmacist in Serving Patients p. 1 Filling the Medication Order p. 3 Receiving the Medication Order p.
Preface p. ix About the PCTB Examination p. xii Assisting the Pharmacist in Serving Patients p. 1 Filling the Medication Order p. 3 Receiving the Medication Order p. 4 The Retail Medication Order p. 6
Alabama Medicaid Pharmacy Override
Alabama Medicaid Pharmacy Override Therapeutic Duplication, Early Refill, Maximum Unit, Prescription Limit Switchover, Dispense as Written, Accumulation Edit, Maintenance Supply Opt Out, and Maximum Cost
Supplementary Online Content
Supplementary Online Content Choudhry NK, Krumme AA, Ercole PM, et al. Effect of reminder devices on medication adherence: the REMIND randomized clinical trial. JAMA Int Med. Published online February
Supplementary Online Content
Supplementary Online Content Lin Y-S, Chen Y-L, Chen T-H, et al. Comparison of Clinical Outcomes Among Patients With Atrial Fibrillation or Atrial Flutter Stratified by CHA 2 DS 2 -VASc Score. JAMA Netw
Mini PTCE Practice Exam
Mini PTCE Practice Exam Developed by the pharmacy educators at www.pharmtechpros.com This is a 33-question mini practice exam that gives you a taste of our full practice exam. This exam was created by
UNIT I EVOLUTION OF THE PHARMACY
Contents UNIT I EVOLUTION OF THE PHARMACY........................ 1 Chapter 1 Pharmacy History................................................. 3 Egyptian History 4 Greek Influence 4 British Apothecaries
Pharmacy Benefit Management
Benefit Management Measures At A Glance Updated: 10/8/2015 Page 1 of 7 Benefit Management Mandatory Measures (6) Note: Mandatory measures are those measures that are a requirement of accreditation and
Note: Mandatory measures are those measures that are a requirement of accreditation and must be reported to URAC on an annual basis.
COMMUNITY PHARMACY V1.1 MANDATORY S Note: Mandatory measures are those measures that are a requirement of accreditation and must be reported to URAC on an annual basis. # NAME DESCRIPTION NUMERATOR DENOMINATOR
Note: Mandatory measures are those measures that are a requirement of accreditation and must be reported to URAC on an annual basis.
Note: Mandatory measures are those measures that are a requirement of accreditation and must be reported to URAC on an annual basis. DESCRIPTION NUMERATOR DENOMINATOR DM2012-12 Portion of Days Covered
Condition/Procedure Measure Compliance Criteria Reference Attribution Method
Premium Specialty: Cardiology Credentialed Specialties include: Cardiac Diagnostic, Cardiology, Cardiovascular Disease, Clinical Cardiac Electrophysiology, and Interventional Cardiology This document is
Supplementary Online Content
Supplementary Online Content Song Z, Ayanian JZ, Wallace J, He Y, Gibson TB, Chernew ME. Unintended consequences of eliminating Medicare payments for consultations. JAMA Intern Med. Published online November
Cardiac Drugs: Chapter 9 Worksheet Cardiac Agents. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate.
Complete the following. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate. 2. drugs affect the force of contraction and can be either positive or negative. 3.
Appropriate Use & Safety Edits
Appropriate Use & Safety Edits Envolve Pharmacy Solutions provides a variety of safety edits to promote the use of the right medication, in the right patient, at the right time. These edits are routinely
MEASURE STEWARD Pharmacy Quality Alliance (PQA) D ATA SOURCE Enrollment; U R A C DOMAIN Engagement & Experience of Care
MANDATORY S Note: Mandatory measures are those measures that are a requirement of accreditation and must be reported to URAC on an annual basis. DM2012-12 DTM2015-01 Portion of Days Covered (PDC) Adherence
2017 URAC PHARMACY BENEFIT MANAGEMENT PERFORMANCE MEASUREMENT: AGGREGATE SUMMARY PERFORMANCE REPORT
2017 URAC PHARMACY BENEFIT MANAGEMENT PERFORMANCE MEASUREMENT: AGGREGATE SUMMARY PERFORMANCE REPORT December 2017 Table of Contents Executive Summary... 1 Pharmacy Benefit Management Organization Characteristics...
Fundamentals of Pharmacology
West Los Angeles College Worksheet #1 Fundamentals of Pharmacology Multiple Choice Identify the choice that best completes the statement or answers the question. 1. By which of the following routes are
Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone
Index Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone Medication GAD glutamic acid decarboxylase GLP-1 glucagon-like peptide 1 NPH neutral
Chapter 1: Fundamentals of Pharmacology Test Bank
Chapter 1: Fundamentals of Pharmacology Test Bank MULTIPLE CHOICE 1. By which of the following routes are drugs administered directly into the bloodstream? a. Enteral b. Transdermal c. Transmucosal d.
Beta-blockers. Atenolol. Propranolol. Bisoprolol. Metoprolol. Labetalol. Carvedilol.
Drugs of CVS Beta-blockers Atenolol. Propranolol. Bisoprolol. Metoprolol. Labetalol. Carvedilol. Atenolol.cardioselective Propranolol, nonselective Bisoprolol, cardioselective Metoprolol Carvedilol, alpha
Index. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A ACCORD (Action to Control Cardiovascular Disease and Diabestes), blood pressure goal, 74 ACEIs (Angiotensin-converting enzyme inhibitors),
Disease Management. Measures At A Glance
s At A Glance Updated: 11/2/2017 Page 1 of 7 Cross Cutting Mandatory s (4) Note: Mandatory measures are those measures that are a requirement of accreditation and must be reported to URAC on an annual
History Note: Authority G.S ; ; ; Eff. May 1, 1997; Amended Eff. January 1, 2015; March 1, 2013.
21 NCAC 46.1412 PHYSICAL REQUIREMENTS A health care facility pharmacy shall have sufficient floor space allocated to it to ensure that drugs are prepared in sanitary, well lighted, and enclosed places.
Chapter 2 ~ Cardiovascular system
Chapter 2 ~ Cardiovascular System: General Section 1 of 6 Chapter 2 ~ Cardiovascular system 2.1 Positive inotropic drugs 2.1.1 Cardiac glycosides DIGOXIN 2.2 Diuretics Elixir 50micrograms in 1ml Injection
Chapter 10 Worksheet Blood Pressure and Antithrombotic Agents
Complete the following. 1. A layer of cells lines each vessel in the vascular system. This layer is a passive barrier that keeps cells and proteins from going into tissues; it also contains substances
Patient-Centered Primary Care Scorecard Measures
Patient-Centered Primary Care Scorecard Measures Acute and Chronic Care Management Measures Medication Adherence Proportion of Days Covered (PDC): Oral Diabetes Identifies patients with at least two prescriptions
Chapter 23. Media Directory. Cardiovascular Disease (CVD) Hypertension: Classified into Three Categories
Chapter 23 Drugs for Hypertension Slide 37 Slide 41 Media Directory Nifedipine Animation Doxazosin Animation Upper Saddle River, New Jersey 07458 All rights reserved. Cardiovascular Disease (CVD) Includes
Changes to the Eighth Edition
Pharmacy Practice and the Law, Eighth Edition Includes Navigate 2 Advantage Access By Richard R. Abood, BS Pharm, JD-Professor Emeritus Pharmacy Practice, Thomas J. Long School of Pharmacy and Health Sciences,
Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name
Program Metrics The list below includes the metrics that will be calculated by the PINNACLE Registry for the outpatient office setting. These include metrics for, Atrial Fibrillation, Hypertension and.
DECLARATION OF CONFLICT OF INTEREST
DECLARATION OF CONFLICT OF INTEREST Is there a mortality risk associated with aspirin use in heart failure? Results from a large community based cohort Margaret Bermingham, Mary-Kate Shanahan, Saki Miwa,
PATIENT-IMPACT SCORECARD
UNDERSTANDING THE GSC PATIENT-IMPACT SCORECARD What is the GSC Patient-Impact Scorecard? The GSC Patient-Impact Scorecard shows pharmacy performance scores for GSC patients during the period indicated.
STARS SYSTEM 5 CATEGORIES
TMG STARS 2018 1 2 STARS Program Implemented in 2008 by CMS. Tool to inform beneficiaries of quality of various health plans 5-star rating system Used to adjust payments to health plans (bonus to plans
Coordinators of the Summer School. President of the Hellenic Atherosclerosis Society
SCIENTIFIC PROGRAM Thursday, June 29 t h, 2017 15.00 15.45 Registration desk open 15.45 16.00 Welcome address E. Liberopoulos K. Tziomalos Coordinators of the Summer School Welcome address C. Pitsavos
Chronic heart failure: management of chronic heart failure in adults in primary and secondary care (partial update)
Chronic heart failure: management of chronic heart failure in adults in primary and secondary care (partial update) NICE guideline Apendix C The algorithms Draft for consultation, January 2010 Chronic
I have no disclosures. Disclosures
I have no disclosures Disclosures What is Heart Failure? Heart Failure (HF) A complex clinical syndrome where patients present with symptoms (i.e. dyspnea, fatigue, fluid retention) that result from any
STANDARD treatment algorithm mmHg
STANDARD treatment algorithm 130-140mmHg (i) At BASELINE, If AVERAGE SBP 1 > 140mmHg If on no antihypertensive drugs: Start 1 drug: If >55 years old / Afro-Caribbean: Calcium channel blocker (CCB) 2 If
DNA. Genetic Screening for Drug Response and Adverse Drug Reactions. Your First Step Towards Total Health and Vitality PATIENT S GUIDE
DNA PGx Genetic Screening for Drug Response and Adverse Drug Reactions Your First Step Towards Total Health and Vitality PATIENT S GUIDE Find Out Which Medications are Safe and Ef fective for You When
Performance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set
Unless indicated, the PINNACLE Registry measures are endorsed by the American College of Cardiology Foundation and the American Heart Association and may be used for purposes of health care insurance payer
Modernized Reference Drug Program
Modernized Reference Drug Program Monitoring Report For the period ending May 31, 2017 Issued: November 2017 Published by: Pharmaceutical Services Division and Health Sector Information, Analysis and Reporting
CARDIAC REHABILITATION PROGRAMME:- MEDICATION
CARDIAC REHABILITATION PROGRAMME:- MEDICATION AIM OF THIS SESSION Understand the reasons for taking your medications, Discuss the common side effects associated with these medications - knowing when to
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Myocardial infarction: secondary prevention in primary and secondary care for patients following a myocardial infarction 1.1
Loop diuretic conversion table
Nov 15, 2012. 5. If patient remains volume overloaded with inadequate response to escalated therapy, initiate continuous infusion loop diuretic and consider addition of a thiazide/thiazidelike diuretic
Heart Failure (HF) Treatment
Heart Failure (HF) Treatment Heart Failure (HF) Complex, progressive disorder. The heart is unable to pump sufficient blood to meet the needs of the body. Its cardinal symptoms are dyspnea, fatigue, and
Steps Against Recurrent Stroke (STARS)
Steps Against Recurrent Stroke (STARS) Take steps against recurrent stroke by making the necessary changes in your life Your Guide to Ischemic What Happened to Me? You had a stroke. The stroke you had
Chapter / Section / Drug
2 Cardiovascular System 2.1 Positive inotropic drugs Digoxin Digoxin specific antibody ( DigiFab ) 2.2 Diuretics 2.2.1 Thiazides and related diuretics Indapamide (1 st Line) Bendroflumethiazide Metolazone
ITdumpsFree. Get free valid exam dumps and pass your exam test with confidence
ITdumpsFree http://www.itdumpsfree.com Get free valid exam dumps and pass your exam test with confidence Exam : PTCE Title : Pharmacy Technician Certification Exam Vendor : Medical Tests Version : DEMO
Plan Change Alert. New Market Priced Drug (MPD) Program Effective 11/1/2016. Alaska United Food and Commercial Workers Trust
Plan Change Alert New Market Priced Drug (MPD) Program Effective 11/1/2016 Plan Sponsor Alaska United Food and Commercial Workers Trust Geographic Area Alaska Number of Participants Serviced 2,000 Announcement
By Prof. Khaled El-Rabat
What is The Optimum? By Prof. Khaled El-Rabat Professor of Cardiology - Benha Faculty of Medicine HT. Introduction Despite major worldwide efforts over recent decades directed at diagnosing and treating
Identification of patients with heart failure and PREserved systolic Function : an Epidemiologic Regional study
Identification of patients with heart failure and PREserved systolic Function : an Epidemiologic Regional study Dr. Antonio Magaña M.D. (on behalf I-PREFER investigators group) Stockholm, Sweden, August
Neprilysin Inhibitor (Entresto ) Prior Authorization and Quantity Limit Program Summary
Neprilysin Inhibitor (Entresto ) Prior Authorization and Quantity Limit Program Summary FDA APPROVED INDICATIONS DOSAGE 1 Indication Entresto Reduce the risk of cardiovascular (sacubitril/valsartan) death
Objectives. Objectives 9/11/2012. Chapter 12 Pharmacology. Copyright 2013 by Jones & Bartlett Learning, LLC, an Ascend Learning Company
Chapter 12 Pharmacology Objectives Define the terms drug and pharmacology Recall the four names given to a drug Identify the various laws and regulatory agencies that regulate drug administration Describe
Layered Approaches to Studying Drug Responses
Layered Approaches to Studying Drug Responses Brian B Hoffman, MD Chief of Medicine VA Boston Health Care System Professor of Medicine Harvard Medical School Conflict of Interest: US Federal Grant Funding
Back to Basics: The Basics of Medication Monitoring
DIAMOND PHARMACY SERVICES Back to Basics: The Basics of Medication Monitoring Presented by: Dr. Deborah Milito, Pharm. D., CGP. Director of Clinical and Consultant Services Skilled Division Annual Educational
Drug Therapy Management
Measures At A Glance Updated: 11/01/2018 2018 Page 1 of 9 Mandatory Measures (10) Note: Mandatory measures are those measures that are a requirement of accreditation and must be reported to on an annual
Adapted d from Federation of Health Regulatory Colleges of Ontario Template Last Updated September 18, 2017
Insert Logo or Org Name Here Primary Care Medical Directive for Hypertension Management Adapted d from Federation of Health Regulatory Colleges of Ontario Template Last Updated September 18, 2017 Title:
Medicinal Chemistry I Examination December 7, 2007 Name Med. Chem. # THERE ARE TWELVE PAGES IN THIS EXAM!
Medicinal hemistry Examination December 7, 2007 ame Med. hem. # 1 TERE ARE TWELVE PAGE T EXAM! Part. 60 Points (30 Questions; 2 Points Each) elect the BET answer for each of the following. 1. The drug
Brown-Lupton Health Service Texas Christian University Campus P.O. Box Fort Worth, TX Dear Student,
Brown-Lupton Health Service Texas Christian University Campus P.O. Box 297400 Fort Worth, TX 76129 817-257-7940 Dear Student, Enclosed you will find our policies, procedures and student consent form for
PART VI: SUMMARY OF THE RISK MANAGEMENT PLAN
PART VI: SUMMARY OF THE RISK MANAGEMENT PLAN VI.1 Summary of activities in the risk management plan The summary below was prepared based on the information included in Part II, IV and V of the present
Supplementary Online Content
Supplementary Online Content Renoux C, Vahey S, Dell Aniello S, Boivin J-F. Association of selective serotonin reuptake inhibitors with the risk for spontaneous intracranial hemorrhage. JAMA Neurol. Published
Mail Service Pharmacy
Mail Service s At A Glance Disclaimer: reserves the right to update its measures and measure sets to maintain measure relevancy and to remedy any unintended consequences that may arise during implementation.
Target dose achievement of evidencebased medications in patients with heart failure with reduced ejection fraction attending a heart failure clinic
Target dose achievement of evidencebased medications in patients with heart failure with reduced ejection fraction attending a heart failure clinic June Chen 1, Charlotte Galenza 1, Justin Ezekowitz 2,3,
Pharmacy Costs: Can I Make a Difference?
Pharmacy Costs: Can I Make a Difference? Pharmaceutical Market Dynamics What is driving Rx cost up? No New Blockbusters Patent Expirations OTC Market Dynamics Availability Pharmaceutical Companies Unfortunately,
STATE UNIVERSITY OF NEW YORK COLLEGE OF TECHNOLOGY CANTON, NEW YORK. COURSE OUTLINE NURS 204 Pharmacology IV. Prepared By: John Conklin
STATE UNIVERSITY OF NEW YORK COLLEGE OF TECHNOLOGY CANTON, NEW YORK COURSE OUTLINE NURS 204 Pharmacology IV Prepared By: John Conklin SCHOOL OF SCIENCE, HEALTH AND CRIMINAL JUSTICE Nursing Department April
Cardiology Pharmacist. Melanie Madorsky, PharmD, BCPS TSHP Annual Meeting April 7, 2018
Cardiology Pharmacist Melanie Madorsky, PharmD, BCPS TSHP Annual Meeting April 7, 2018 Melanie.Madorsky@memorialhermann.org Objectives Explain the daily responsibilities of the Cardiology Pharmacist Identify
Adult Diabetes Clinician Guide NOVEMBER 2017
Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Adult Diabetes Clinician Guide Introduction NOVEMBER 2017 This evidence-based guideline summary is based on the 2017 KP National Diabetes Guideline.
Possible Cardiovascular System Abnormality. Opening and closing of a coronary artery Inflammation of the outside lining of the heart
JAMES L. MARCUM Symptom Chest pain (2) Shortness of breath (dyspnea) Possible Cardiovascular System Abnormality Complete blockage of a coronary artery leading to the heart Partial blockage Opening and
*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge.
Quality ID #5 (NQF 0081): Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) National Quality
Metformin should be considered in all patients with type 2 diabetes unless contra-indicated
November 2001 N P S National Prescribing Service Limited PPR fifteen Prescribing Practice Review PPR Managing type 2 diabetes For General Practice Key messages Metformin should be considered in all patients
Medical Policy An independent licensee of the Blue Cross Blue Shield Association
Neprilysin Inhibitor (Entresto ) Page 1 of 6 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Neprilysin Inhibitor (Entresto ) Prime Therapeutics will review Prior
Diabetes and the Elderly: Medication Considerations When Determining Benefits and Risks
Diabetes and the Elderly: Medication Considerations When Determining Benefits and Risks Gretchen M. Ray, PharmD, PhC, BCACP, CDE Associate Professor UNM College of Pharmacy September 7 th, 2018 DISCLOSURES
POISONS SCHEDULING. Monique Reyes Senior Pharmaceutical Officer Pharmaceutical Regulatory Unit NSW Ministry of Health
POISONS SCHEDULING Monique Reyes Senior Pharmaceutical Officer Pharmaceutical Regulatory Unit NSW Ministry of Health Topics Schedules of the Poisons Standard (Cth) Poisons and Therapeutic Goods Act 1966
Volume 6; Number 1 January 2012 NICE CLINICAL GUIDELINE 127: HYPERTENSION CLINICAL MANAGEMENT OF PRIMARY HYPERTENSION IN ADULTS (AUGUST 2011)
Volume 6; Number 1 January 2012 NICE CLINICAL GUIDELINE 127: HYPERTENSION CLINICAL MANAGEMENT OF PRIMARY HYPERTENSION IN ADULTS (AUGUST 2011) What s new in hypertension? NICE has issued an updated Clinical
Position Statement on ALDOSTERONE ANTAGONIST THERAPY IN CHRONIC HEART FAILURE
Position Statement on ALDOSTERONE ANTAGONIST THERAPY IN CHRONIC HEART FAILURE Over 8,000 patients have been studied in two well-designed placebo-controlled outcome-driven clinical trials to evaluate the
CHAPTER 1 COMMUNITY PHARMACY M.ASHOKKUMAR DEPT OF PHARMACY PRACTICE SRM COLLEGE OF PHARMACY SRM UNIVERSITY
CHAPTER 1 COMMUNITY PHARMACY M.ASHOKKUMAR DEPT OF PHARMACY PRACTICE SRM COLLEGE OF PHARMACY SRM UNIVERSITY COMMUNITY PHARMACY OPERATIONS Technician Duties Related to Dispensing Over-the-Counter Drugs and
Saudi Heart Failure Guidelines. Waleed AlHabeeb, MD, MHA Consultant Heart Failure Cardiologist President of the Saudi Heart Failure Group
Saudi Heart Failure Guidelines Waleed AlHabeeb, MD, MHA Consultant Heart Failure Cardiologist President of the Saudi Heart Failure Group Heart Failure Expert committee The Heart Failure Expert Committee,
Quick Guide MEDICATIONS 7th Edition Evan Sisson, Pharm.D., MHA, CDE
Quick Guide to MEDICATIONS 7th Edition Evan Sisson, Pharm.D., MHA, CDE Adapted from The Art and Science of Diabetes Self-Management Education Desk Reference 2017, American Association of Diabetes Educators,
Hypertension. Penny Mosley MRPharmS
Hypertension Penny Mosley MRPharmS Outline of presentation Introduction to hypertension Physiological control of arterial blood pressure What determines our bp? What determines the heart rate? What determines
Practice-Level Executive Summary Report
PINNACLE Registry Metrics 0003, Test Practice_NextGen [Rolling: 1st April 2015 to 31st March 2016 ] Generated on 5/11/2016 11:37:35 AM American College of Cardiology Foundation National Cardiovascular
Hypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B)
Practice Guidelines and Principles: Guidelines and principles are intended to be flexible. They serve as reference points or recommendations, not rigid criteria. Guidelines and principles should be followed
Cardiovascular System
Therapeutic Agents for the Lecture 04 Therapeutic Agents for the Cardiovascular System Cardiovascular System Chapter 18 1 Anatomy of the Cardiovascular System OBJECTIVES Describe the major components of
Steps Against Recurrent Stroke (STARS)
Steps Against Recurrent Stroke (STARS) Take steps against recurrent stroke by making the necessary changes in your life. Your Guide to Ischemic What happened to me? You had a stroke. The stroke you had
Atorvastatin route of administration
Atorvastatin route of administration 8-3-2017 Atorvastatin Calcium. Atorvastatin Calcium Combinations; Routes.. Petrella G et al. Effects of simvastatin and atorvastatin administration on. 1-3-2017 Atorvastatin
UTHEALTH HOUSTON CCTS BIOBANK VARIABLE LIST
Please check the requested variables:, and/or. Obtained at Initial Hospital Recruitment Demographics: Age Gender Marital Status Ethnicity Race Height (inches) Weight (pounds) Main language spoken Socioeconomic
OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE 20/5/12.5 MG National Drug Code Directory
13668-397-90 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE 20/5/12.5 MG The Drug Listing Act of 1972 requires registered drug establishments to provide the Food and Drug Administration (FDA)
Supplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Wanner C, Inzucchi SE, Lachin JM, et al. Empagliflozin and
Management of Hypertension in special groups. DR-Mohammed Salah Assistant Lecturer of Cardiology Mansoura University
Management of Hypertension in special groups BY DR-Mohammed Salah Assistant Lecturer of Cardiology Mansoura University AGENDA SPECIAL GROUPS SPECIFIC DRUDS FOR SPECIAL GROUPS TARGET BP FOR SPECIAL GROUPS:
Hypertension and diabetes treatments and risk of adverse outcomes among breast cancer patients. Lu Chen
Hypertension and diabetes treatments and risk of adverse outcomes among breast cancer patients Lu Chen A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy
Pharmacy Federal Laws and Regulations
Pharmacy Federal Laws and Regulations Chapter 2 1 Lesson 2.1 Major Federal Laws Affecting the Pharmacy Technician 1. Identify the major laws within which technicians need to work when performing nondiscretionary
SUMMARY OF PRODUCT CHARACTERISTICS 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS PRODUCT SUMMARY 1. NAME OF THE MEDICINAL PRODUCT Sterile Potassium Chloride Concentrate 15%. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 15% of Potassium Chloride in
Know Your Numbers Blood Pressure Cholesterol Blood Sugar
Know Your Numbers Blood Pressure Cholesterol Blood Sugar 2015 Wellness Warriors Sponsored by: Wayne State University Presented by: Debbie Cavender, RDN STRATEGIC WELLNESS, LLC The information in this presentation
MEDICINES CONTROL AGENCY. Guideline for Dispensing of Medicines
MEDICINES CONTROL AGENCY Guideline for Dispensing of Medicines FORWARD The Medicines Control Agency (MCA) established by an Act of Parliament and assented to on 24th December 2014 is mandated to regulate
NCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT
NCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT CONTENTS PATIENTS ADMITTED WITH HEART FAILURE...4 Demographics... 4 Trends in Symptoms... 4 Causes and Comorbidities
MATERIAL SAFETY DATA SHEET
MATERIAL SAFETY DATA SHEET 1. IDENTIFICATION OF THE SUBSTANCE AND THE COMPANY Material Manufacturer Distributor Trandolapril Tablets 1 mg, 2 mg & 4 mg Tablets Lupin Limited Mumbai 400 098 INDIA Lupin Pharmaceuticals,
Quality Payment Program: Cardiology Specialty Measure Set
Quality Payment Program: Cardiology Specialty Set Title Number CMS Reporting Method(s) Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for
6/7/2017 CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE DISCLOSURE OBJECTIVES
CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE John Karwoski, RPh, MBA DISCLOSURE I, John Karwoski, RPH, MBA have business relationships with the companies MOBIUS THERAPEUTICS, LLC, Cubex, and
Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures
Supplementary Data Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures Quintiles of Systolic Blood Pressure Quintiles of Diastolic Blood Pressure Q1 Q2
In Australia, brand substitution of
Pharmaceutical brand substitution in Australia are there multiple switches per prescription? Abstract Background: In Australia, brand substitution by pharmacists has been possible since 1994. There is
Antihypertensive Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia
Antihypertensive Agents Part-2 Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Agents that block production or action of angiotensin Angiotensin-converting
Star Measures At-A-Glance Guide
Star Measures At-A-Glance Guide This guide alerts you to important preventive care and services that you can provide to patients to help boost Star Ratings. ASSESSMENT AND SCREENING At Easy Choice, we
First line treatment of primary hypertension
First line treatment of primary hypertension Dr. Vijaya Musini Assistant Professor, Dept. Anesthesiology, Pharmacology and Therapeutics Manager, Drug Assessment Working Group Therapeutics Initiative Editor,
Reviewers. Michelle L. Blesi, BA, AA, CMA (AAMA) Program Director/Instructor Medical Assistant Program Century College Coon Rapids, Minnesota
Reviewers Michelle L. Blesi, BA, AA, CMA (AAMA) Program Director/Instructor Medical Assistant Program Century College Coon Rapids, Minnesota Candy Dailey, RN, MSN, CMA (AAMA) Director, MA Program Director